Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company developing therapeutic programs for rare neurological disorders[2]. Founded in 2014[3], the company is headquartered in New York at Hudson Commons, 441 9th Avenue[1].

Leadership & org chart

Dr. Jeremy M. LevinChairperson ASArielle Stanford, MDVice President Clinical and Medical Sciences KNKevin NorrettChief Business Officer MAMeg AlexanderPresident and Chief Executive Officer

NYC headquarters

The company's own site places it in New York: Website states 'Our Headquarters' at 'Hudson Commons 441 9th Avenue New York, NY 10001'.[1]

Something wrong or missing? Send a correction. Fixed within 24 hours.